Franklin Resources’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.63M | Buy |
430,240
+410,034
| +2,029% | +$8.23M | ﹤0.01% | 1176 |
|
|
2025
Q1 | $398K | Buy |
20,206
+55
| +0.3% | +$1.08K | ﹤0.01% | 2349 |
|
|
2024
Q4 | $453K | Hold |
20,151
| – | – | ﹤0.01% | 2325 |
|
|
2024
Q3 | $559K | Buy |
+20,151
| New | +$559K | ﹤0.01% | 2227 |
|
|
2023
Q3 | – | Sell |
-11,685
| Closed | -$238K | – | 2694 |
|
|
2023
Q2 | $238K | Buy |
+11,685
| New | +$238K | ﹤0.01% | 2297 |
|